识别,过程和管理渐进性肺纤维化
Anna J Podolanczuk1, Evans R Fernández Peréz
1Weill Cornell Medicine, 425 East 61st St, New York, NY 10065.
The American journal of managed care
|November 4, 2024
概括
渐进性肺纤维化 (PPF) 描述了间歇性肺病 (ILD) 患者肺纤维化恶化的情况. 早期发现和多学科管理对于这种严重疾病至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 放射学 放射学是一门学科.
- 临界护理医学 临界护理医学
背景情况:
- 渐进性肺纤维化 (PPF) 被定义为肺纤维化在间歇性肺病 (ILD) 患者中恶化的肺纤维化,不包括异常性肺纤维化 (IPF).
- 识别PPF通常依赖于包括肺功能下降,症状恶化和成像纤维化增加在内的标准.
- 预测哪些患者将发展PPF仍然具有挑战性,尽管已知纤维化的ILD进展的风险因素.
研究的目的:
- 在间歇性肺病 (ILD) 中定义渐进性肺纤维化 (PPF).
- 突出预测PPF发展的挑战.
- 强调PPF监测和多学科管理的重要性.
主要方法:
- 对PPF识别的拟议标准的审查.
- 对纤维化ILD进展的风险因素的分析.
- 讨论监测策略,包括肺功能测试.
- 检查PPF目前的管理方法.
主要成果:
- 在ILD患者中,PPF的特征是渐进的肺纤维化.
- 对于PPF的标准通常涉及强迫生命能力的下降,症状恶化和放射性进展.
- 密切监测对于早期检测PPF至关重要.
- PPF与显著的住院和死亡率有关.
结论:
- 渐进性肺纤维化 (PPF) 需要对间歇性肺病 (ILD) 患者进行警监测和早期干预.
- 包括药物和支持性护理在内的综合,多学科的方法对于管理PPF至关重要.
- 建议在疾病过程的早期整合息护理讨论,以满足个性化的患者需求.
更多相关视频
07:38A Multimodal Imaging Approach Based on Micro-CT and Fluorescence Molecular Tomography for Longitudinal Assessment of Bleomycin-Induced Lung Fibrosis in Mice
Published on: April 13, 2018
11.4K
07:11Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
82
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:24Cystic Fibrosis: Management
143
Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
Sinus disease and chronic...
143
01:28Pneumonia IV: Management
300
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
300
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.6K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.6K
01:20COPD: Pathogenesis and Clinical Features
235
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
235
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K